Akèy › Dyabèt Tip 2 › Michigan
Etid klinik pou Dyabèt Tip 2 nan Michigan
27 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Michigan.
Vil nan Michigan
Tèks ofisyèl etid la (Anglè)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Michigan, Ann Arbor
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Michigan, Ann Arbor
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06906640A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Northern Pines Health Center - Buckley, Buckley
- Revival Research Institute, LLC - Dearborn, Dearborn
- Arcturus Healthcare - Troy Internal Medicine Research Division, Troy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Revival Research Institute, LLC - Dearborn, Dearborn
- Aa Mrc Llc, Flint
- Elite Research Center, LLC, Flint
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Revival Research Institute, LLC, Dearborn
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Northern Pines Hlth Ctr, PC, Buckley
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Henry Ford Hospital, Detroit
- Trinity Health Michigan Heart, Ypsilanti
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Aa Mrc Llc, Flint
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Farmington Hills
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Southfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Elixia Health - Michigan Kidney Consultants, LLC - Elixia - PPDS, Pontiac
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Michigan, Ann Arbor
- Elixia Michigan Kidney Consultants, Pontiac
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Southfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Great Lakes Research Inst., Southfield
Ap rekriteFaz 3
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Oakland Medical Research Center, Troy
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Henry Ford Health System, Detroit
- Elite Research Center, Flint
- Arcturus Healthcare, PLC., Troy
- ak 1 plis
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335Mechanisms of Fatigability With Diabetes
- University of Michigan, Ann Arbor
Ap rekrite
Laj 30 a 85 · Tout sèks · Mizajou Sep 1, 2026 · NCT04442451A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Southfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662044A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Troy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Henry Ford Health System, Detroit
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599982Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Henry Ford Health, Detroit
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07521475Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Henry Ford Health Systems, Detroit
Ap rekrite
Laj 14 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07579702Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 14 a 18 · Tout sèks · Mizajou Jul 13, 2026 · NCT06007404Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
- University of Michigan, Ann Arbor
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jun 12, 2026 · NCT06574035Mechanism of SGLT2 Inhibition in the Kidney
- University of Michigan, Ann Arbor
Ap rekriteFaz 4Mande peman pou patisipan yo
Laj 18 a 80 · Tout sèks · Mizajou Jun 11, 2026 · NCT06291155HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Arcturus Healthcare, PLC, Troy Internal Medicine Research Division, Troy
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929RESET System Pivotal Trial (Rev F)
- Michigan Medicine, Division of Gastroenterology and Hepatology, Ann Arbor
Ap rekrite
Laj 22 a 65 · Tout sèks · Mizajou Jul 18, 2024 · NCT04101669Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.